Northeast Financial Consultants’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q3 | – | Sell |
-102
| Closed | -$13K | – | 165 |
|
|
2016
Q2 | $13K | Buy |
102
+50
| +96% | +$6.37K | 0.01% | 150 |
|
|
2016
Q1 | $6K | Hold |
52
| – | – | ﹤0.01% | 136 |
|
|
2015
Q4 | $10K | Hold |
52
| – | – | 0.01% | 131 |
|
|
2015
Q3 | $9K | Hold |
52
| – | – | ﹤0.01% | 140 |
|
|
2015
Q2 | $33K | Hold |
52
| – | – | 0.01% | 150 |
|
|
2015
Q1 | $27K | Hold |
52
| – | – | 0.01% | 141 |
|
|
2014
Q4 | $28K | Hold |
52
| – | – | 0.01% | 132 |
|
|
2014
Q3 | $79K | Hold |
52
| – | – | 0.04% | 134 |
|
|
2014
Q2 | $71K | Buy |
+52
| New | +$71K | 0.04% | 128 |
|